• Journal of Preventive Medicine and Public Health
• /
• 제37권4호
• /
• pp.353-358
• /
• 2004

Objective : To determine the quality of life and cost consequences for deaf adults who received a cochlear implant. Methods : The data from 11 patients, post-lingual deaf adults who received cochlear implants from 1990 to 2002, underwent cost-utility analysis. The average age of the participants was 49.6 years. The main outcomes were direct cost per quality-adjusted life-year (QALY) using the visual analog scale (VAS), health utility index (HUI), EuroQol (EQ-5D), and quality well-being (QWB), with costs and utilities being discounted 3% annually. Results : Recipients had an average of 5.6 years of implant use. Mean VAS scores increased by 0.33, from 0.27 before implantation to 0.60 at survey. HUI scores increased by 0.36, from 0.29 to 0.65, EQ-5D scores increased by 0.26, from 0.52 to 0.78, and QWB scores increased by 0.16, from 0.45 to 0.61. Discounted direct costs were $22,320, yielding $19,223/QALY using VAS, $17,387/QALY using HUI, $24,604/QALY using EQ-5D, and $40,474/QALY using QWB. Cost-utility ratios using VAS, HUI, and EQ-5D were all below $25,000 per QALY, except using QWB. Conclusion : Cochlear implants in post-lingual deaf adult have a positive effect on quality of life at reasonable direct costs and appear to produce a net saving to society.

• 한국산림과학회지
• /
• 제104권2호
• /
• pp.230-238
• /
• 2015

현재 우리나라의 주요 임업기계에 의한 임목수확작업시스템에서 벌목 및 조재, 집재, 소운재, 파쇄 등의 목재생산 및 파쇄작업에 대한 작업비용을 분석하여, 산림바이오매스 이용을 위한 효율적인 임목수확작업시스템을 구축하기 위한 기초자료를 제공하고자 수행하였다. 임목수확작업시스템의 작업비용을 분석한 결과, 체인톱에 의한 벌목 및 조재와 타워야더에 의한 집재, 임내작업차에 의한 소운재, 트럭에 의한 운재작업으로 이루어진 임목수확작업시스템 D가 63,482원/$m^3$으로 가장 적은 비용이 소요되는 것으로 나타났다. 또한, 산림바이오매스 이용을 위한 작업시스템의 작업비용을 분석한 결과, 소형 목재파쇄기에 의한 현장파쇄, 임내작업차에 의한 칩 소운반, 트럭에 의한 칩 운반작업의 작업시스템 E가 90,770원/ton으로 가장 적은 비용이 산출되었다. 따라서, 이들의 결과가 임목수확작업 및 산림바이오매스 이용을 위한 효율적인 작업시스템이라고 판단된다.

• 한국임상약학회지
• /
• 제28권2호
• /
• pp.131-137
• /
• 2018

Background: In South Korea, 22.3% of women ${\geq}50years$ of age and 37% of women ${\geq}70years$ of age visit the doctor to obtain treatment for osteoporosis. According to the analysis of the National Health Insurance Services claim data between 2008 and 2012, the number and incidence of hip and vertebral fractures increased during the same period. Denosumab, a newly marketed medicine in Korea, is the first RANK inhibitor. Methods: A cost-utility analysis was conducted from a societal perspective to prove the superiority of denosumab to alendronate. A Markov cohort model was used to investigate the cost-effectiveness of denosumab. A 6-month cycle length was used in the model, and all patients were individually followed up through the model, from their age at treatment initiation to their time of death or until 100 years of age. The model consisted of eight health states: well; hip fracture; vertebral fracture; wrist fracture; other osteoporotic fracture; post-hip fracture; post-vertebral fracture; and dead. All patients began in the well-health state. In this model, 5% discounted rate, two-year maximum offset time, and persistence were adopted. Results: The total lifetime costs for alendronate and denosumab were USD 5,587 and USD 6,534, respectively. The incremental cost-effectiveness ratio (ICER) for denosumab versus alendronate was USD 20,600/QALY. Given the ICER threshold in Korea, the results indicated that denosumab was remarkably superior to alendronate. Conclusion: Denosumab is a cost-effective alternative to the oral anti-osteoporotic treatment, alendronate, in South Korea.

• 지역사회간호학회지
• /
• 제32권3호
• /
• pp.356-367
• /
• 2021

Purpose: This study conducted an economic evaluation of hospital-based home care services for the patients who had undergone breast cancer surgery. Methods: A total of 12,483 patients over 18 years of age who had received breast cancer surgery in 26 tertiary hospitals in 2018 were analyzed with the claim data from the Health Insurance Review & Assessment Service using cost-minimization analysis and societal perspectives. Results: There were 156 patients who utilized hospital-based home care services within 30 days after breast cancer surgery, and they received 2.17 (SD=1.17) hospital-based home care service on average. The average total cost was 5,250,028 KRW (SD=1,905,428) for the group receiving continuous hospital-based home care and 6,113,402 KRW (SD=2,033,739) for the group not receiving continuous hospital-based home care (p<.001). The results of the economic evaluation of continuous hospital-based home care services in patients who had undergone breast cancer surgery indicated a total benefit of 953,691,000 KRW, a total cost of 819,004,000 KRW, and a benefit-cost ratio of 1.16 in 2018. Conclusion: Continuous hospital-based home care was considered economically feasible as the total costs for the group receiving continuous hospital-based home care were lower than those of the group not receiving continuous hospital-based home care. Therefore, policy modification and financial incentives are recommended to increase the utilization of hospital-based home care services for patients who had undergone breast cancer surgery.

• 한국산업보건학회지
• /
• 제29권1호
• /
• pp.57-68
• /
• 2019

Objective: The purpose of this study is to propose the benefits of reduction measures according to the occupational radon reference level in order to present basic data for radon management guidelines considering domestic circumstances. Methods: This study uses radon data measured in the subway stations from 2015 to 2016. Of the total of 4,643 cases, 4,231 cases were analyzed excluding the 412 cases where the values were below $300Bq/m^3$. Results: Cost-Benefit analysis was done on the results of the field survey on subway work sites. At the exposure level of $400Bq/m^3$, the ratio between the cost and the benefit was highest at 1 : 1.81(the cost was KRW 1,398,568,032, while the benefit KRW 2,5248,772,841). At the exposure level of $600Bq/m^3$, the ratio of cost and benefit was 1: 1.80, at $300Bq/m^3$ it was 1.72, at $800Bq/m^3$ it was 1.71, at $200Bq/m^3$ it was 1.54, and at $100Bq/m^3$ it was 1.40. Conclusions: Radon management in the workplace provides economic benefits and appropriate reduction strategies are needed. In addition, it is necessary to establish and distribute radon exposure assessment procedures and guidelines for the safety and health of employees when exceeding the exposure standard, and guidelines for radon management in the workplace should be established.

• 한국정보기술학회논문지
• /
• 제17권7호
• /
• pp.123-131
• /
• 2019

본 논문에서는 기존의 관련 연구를 SW 중심의 대가 산정, 비용-편익분석, 보안성 지속서비스 대가 산정으로 구분하여 조사하였고, 사례 분석은 미국과 일본, 국내 A기관을 대상으로 하였다. 이를 바탕으로 현 제도와의 비교를 통해 개선모델을 마련하였다. 비용-효용분석 측면에서 효용성이 높은 서비스 수준 협약(SLA ; Service Level Agreement)과 NIST Cybersecurity Framework를 적용하여 정보보호서비스별 특성과 수행기준, 가중치를 기준으로 대가를 산정하는 방식인 SCS(Security Continuity Service) 성과평가체계 기반 정보보호서비스 대가 산정 모델을 제안한다. 이 모델은 공공기관에서 정보보호서비스 대가를 객관적으로 산정하는 도구로 활용할 수 있다. 또한, 현재 권고수준인 법률을 적용 강제성 수준으로 강화, 국가기관 및 공공기관의 평가제도 개선, 국가인증기관의 정보보호서비스 검증제도 도입, 모든 정보시스템 및 서비스로의 확대 등을 통해 본 제도의 정착될 수 있을 것으로 기대된다.

• 대한두개안면성형외과학회지
• /
• 제23권4호
• /
• pp.163-170
• /
• 2022

Background: Personal mobility devices (PMDs) have become an increasingly popular transport modality globally. With increasing social interest in and demand for PMDs, the number of individuals visiting emergency departments with PMD-related injuries has also increased annually. This study aimed to evaluate injury patterns and treatment costs for patients treated in the department of plastic surgery in a trauma center. Methods: In this retrospective study, data concerning patients with PMD-related injuries from January 2017 to December 2021 were reviewed. The data retrieved included age, sex, alcohol consumption, helmet use, the type of impact, onset of injury, place of first visit, type of injury, admission status, operation status, and treatment cost. Multiple linear regression analysis was performed to determine the effects of various factors on cost. Results: Data were collected from 93 patients. Until 2019, the annual number of PMD-related accidents was less than 10; however, this number increased sharply in 2020. The average cost of hospitalization was USD 7,698 whereas the average cost of non-hospitalization was USD 631. Only fractures had a significant association with total cost in linear regression analysis (p< 0.001). Conclusion: The prevalence of PMD use and related injuries requiring plastic surgery during the study period showed significant health and financial costs both to the patients involved and to society. This cost could be reduced through stricter regulations concerning PMD use, advocating the use of protective gear, and promoting greater awareness of safety measures and of the consequences of PMD-related accidents.

• 한국산업융합학회 논문집
• /
• 제25권6_3호
• /
• pp.1207-1219
• /
• 2022

「Act On Contracts To Which The State Is A Party」 stipulates that the "Construction Standard Production Rate" and "Construction Standard Unit Price" be used as the criteria for determining the estimated price of construction works performed by public institutions. In this regard, issues such as the application scope of the Construction Standard Unit Price, and the effect of budget reduction continue. However, due to the lack of quantitative data on the actual application of Construction Standard Unit Price, it is difficult to objectively evaluate various issues. In order to prepare data for objective evaluation of the Construction Standard Unit Price, this study analyzed the ripple effect of applying the Construction Standard Unit Price based on the bill of quantity. As a result of the analysis, the Construction Standard Unit Price ripple effect in the civil engineering part was 9.2%, and it was analyzed that there was a ripple effect of about 1.9% based on the civil engineering direct cost. In the construction part, the ripple effect was analyzed to be relatively high at 17%, but it was found to have a ripple effect of about 3% in the construction direct cost. Based on the total direct cost, the ripple effect was calculated as 2.2%. Based on the analysis results, it is possible to evaluate the effect of applying the Standard Market Unit Price, and it is expected to be used as basic data to solve issues. As a future study, it is necessary to additionally analyze the ripple effect by Standard Market Unit Price application range (over 10 billion, over 20 billion won, etc.) and delivery system type (comprehensive evaluation, qualification examination, technical bidding, etc.). In addition, it is necessary to study the appropriate ripple effect of the Standard Market Unit Price.

• Nuclear Engineering and Technology
• /
• 제21권1호
• /
• pp.18-31
• /
• 1989

대기오염의 제어가 발전 단가에 미치는 영향을 분석하기 위하여 전산 모델이 개발 되었다. POGEN은 석탄 화력 발전소에 대해 대기오염 제어 비용을 가산한 균등화 발전 단가를 계산한다. 부 프로그램 Pollution은 대기 오염 제어 비용을 가산한 지배 방정식을 사용하여 총 자본 비용과 변동비용을 계산한다. 이 비용은 균등화 발전 단가를 계산하는 부 프로그램 GENeration의 추가 입력으로 사용된다. 탈황설비의 직접 비용에 대한 Pollution을 이용한 결과는 경험이 풍부한 선진국에서 발간된 비용 자료로써 검증하였다. 2001년의 전력 생산비용은 석탄화력발전소에 적용된 세 가지의 규제 시나리오에 의해 추정되었다. 입력 변수의 중요도와 미래 발전소에 대한 입력 변수에 포함된 불확실성 때문에 생기는 불확실도의 전파를 검토하기 위해 Latin Hypercube Sampling과 Multiple Least Squares 방법을 사용하여 민감도 분석과 불확실도 분석을 수행하였다. 가장 민감한 입력 변수는 원자력, 화력 공히 할인률이다. 배출가스제어 비용으로서 9-11 mills/kWh 정도가 추가되어야 한다. 이 비용은 전력 생산비용의 거의 20 퍼센트가 되고, 이에 해당하는 투자비는 1GW 용량의 석탄 화력발전소 초기 투자비용의 40%가 될 것이다. 원자력 발전에 대한 단가는 90퍼센트의 신뢰도로써 32.6-65.9, 석탄 화력에 대해서는 45.5-60.5 mills/kWh가 되며, 엄격한 규제 분위기 하에서는 원자력이 95%의 신뢰도로써 유리할 것이 전망된다.

• Journal of Korea Trade
• /
• 제26권5호
• /
• pp.23-38
• /
• 2022

Purpose - This research intends to find out whether R&D cost stickiness shows differentiated aspects depending on exports in Korea. A cost behavior that indicates a lower rate of costs decrease when sales decrease than the rate of costs increase when sales increase is called cost stickiness. This sticky cost behavior is caused by considering the adjusting costs. This study aims to empirically verify that R&D cost stickiness is greater in export firms than in non-export firms. We also investigate the effect of exports on R&D cost stickiness is nonlinear. Design/methodology - We obtain data for the analysis from Kis-Value and TS2000 from 2012 to 2020. This study tests for R&D cost stickiness of exports using the cost stickiness model developed by Anderson et al. (2003) that is used in a lot of prior literature. To explore the nonlinear behavior of R&D cost stickiness we include a quadratic term of exports in our model. Findings - The results of our analysis are as follows. First, we observed that R&D costs of export firms are more sticky than that of non-export firms. Our result indicated that export firms are less likely to reduce R&D costs in decreasing sales periods in preparation for future sales recovery. Second, our empirical evidence shows that export firms view R&D costs much favorably. However, we hypothesize that the effect of export intensity on R&D costs may not necessarily be linear. Our result shows the effect of exports intensity on R&D stickiness is thus nonlinear, forming a reverse U-shaped curve. When export intensity exceeds a certain threshold, the growth rate of R&D costs appears to be viewed negatively. Firms with relatively high export intensity do not support R&D costs, viewing them as taking away firms' resources from other more productive costs. On the contrary, those with export intensity under the threshold view R&D costs as beneficial and therefore promote further R&D costs when revenue decreases. Originality/value - The results of this research can contribute academically to the expansion of empirical research on R&D cost stickiness. R&D cost stickiness varies by industry. As a result of our research, the managers of export firms recognize the importance of R&D to lead innovation. We expected that this research contributes to further studies on R&D costs and cost stickiness. Second, this research has implications from a business perspectives. Our findings of export firms' R&D stickiness suggest that export firms' managers should consider keeping the stickiness of R&D when revenue decreases because it is essential for exporting firms to maintain their R&D stickiness to secure long-term competitiveness. R&D stickiness can be used on a practical basis to emphasize the need for continuous investment in exporting firms' R&D activities.